Search research articles
Contact Us
Filters
Showing results (191-200 of 220) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717
A H Calvert, D L Alison, S J Harland, et al.
Journal of Medicinal Chemistry
|
October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituent
T R Jones, A H Calvert, A L Jackman, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)
A H Calvert, D R Newell, A L Jackman, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series
P R Marsham, A L Jackman, A J Barker, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)
H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry
|
November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position
L R Hughes, A L Jackman, J Oldfield, et al.
British Journal of Cancer
|
June 1, 2001
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
C A Maxwell-Armstrong, L G Durrant, T J Buckley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statements
D G Allen, J Baak, D Belpomme, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
M Martin, M Spielmann, M Namer, et al.
Journal of Environmental Quality
|
November 9, 2005
Phosphorus, sediment, and Escherichia coli loads in unfenced streams of the Georgia Piedmont, USA
H L Byers, M L Cabrera, M K Matthews, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 220) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717
A H Calvert, D L Alison, S J Harland, et al.
Journal of Medicinal Chemistry
|
October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituent
T R Jones, A H Calvert, A L Jackman, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)
A H Calvert, D R Newell, A L Jackman, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series
P R Marsham, A L Jackman, A J Barker, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)
H C Barlow, K J Bowman, N J Curtin, et al.
Journal of Medicinal Chemistry
|
November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position
L R Hughes, A L Jackman, J Oldfield, et al.
British Journal of Cancer
|
June 1, 2001
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
C A Maxwell-Armstrong, L G Durrant, T J Buckley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1993
Advanced epithelial ovarian cancer: 1993 consensus statements
D G Allen, J Baak, D Belpomme, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines
M Martin, M Spielmann, M Namer, et al.
Journal of Environmental Quality
|
November 9, 2005
Phosphorus, sediment, and Escherichia coli loads in unfenced streams of the Georgia Piedmont, USA
H L Byers, M L Cabrera, M K Matthews, et al.
Page
of 22